Blog Archive

Sunday, May 28, 2017

Just B with IXINITY®

It's refreshing when a company really connects with the community they're providing treatment options for, which is why today, I'm happy to spread the word about the new promotional campaign from Aptevo, the makers of the factor IX treatment, IXINITY® [coagulation factor IX (recombinant)]. 
 
Read below to get the story on how people in the hemophilia B community inspired the campaign, plus see it for yourself at JustBIXperiences.com.

This is a paid public announcement from Aptevo and does not constitute an endorsement of products or services. When you click on the links in this blog entry, you will be directed to the IXINITY website. LA Kelley Communications always advises you to be a savvy consumer when contacting any company; do not reveal identifying information against your will. 
 
 

Finding inspiration from familiar faces

As IXINITY marks its second anniversary as a treatment option for those with hemophilia B, the people behind the product are excited to start the next phase with a fresh new face. They didn't have to look very far, because who better to represent the close-knit hemophilia B community and the company that cares about them than real people actually using IXINITY? 

Introducing…

Just B: Because life is bigger than hemophilia B, make it your IXperience™ with IXINITY.
Please see Important Safety Information for IXINITY below.

An idea that became an identity, inspired by everyone who is redefining what it means to have hemophilia B by living life on your own terms and Just B-ing yourself.

 
By sharing your experiences, your expectations, and your aspirations, you've shown that, regardless of having hemophilia or not, everyone deserves the chance to Just B.

Meet the first people to be featured sharing their IXINITY stories (and see if there are any familiar faces from the community that you recognize) at JustBIXperiences.com.

Plus, find out more about what it means to Just B and get connected in the IXINITY Family Room on Facebook.



IXINITY INDICATIONS AND IMPORTANT SAFETY INFORMATION

What is IXINITY®?
IXINITY [coagulation factor IX (recombinant)] is a medicine used to replace clotting factor (factor IX) that is missing in adults and children at least 12 years of age with hemophilia B. Hemophilia B is also called congenital factor IX deficiency or Christmas disease. Hemophilia B is an inherited bleeding disorder that prevents clotting. Your healthcare provider may give you IXINITY to control and prevent bleeding episodes or when you have surgery.
IXINITY is not indicated for induction of immune tolerance in patients with hemophilia B.
IMPORTANT SAFETY INFORMATION for IXINITY®
  • You should not use IXINITY if you are allergic to hamsters or any ingredients in IXINITY.
  • You should tell your healthcare provider if you have or have had medical problems, take any medicines, including prescription and non-prescription medicines, such as over-the-counter medicines, supplements, or herbal remedies, have any allergies, including allergies to hamsters, are nursing, are pregnant or planning to become pregnant, or have been told that you have inhibitors to factor IX.
  • You can experience an allergic reaction to IXINITY. Contact your healthcare provider or get emergency treatment right away if you develop a rash or hives, itching, tightness of the throat, chest pain, or tightness, difficulty breathing, lightheadedness, dizziness, nausea, or fainting.
  • Your body may form inhibitors to IXINITY. An inhibitor is part of the body's defense system. If you develop inhibitors, it may prevent IXINITY from working properly. Consult with your healthcare provider to make sure you are carefully monitored with blood tests for development of inhibitors to IXINITY.
  • If you have risk factors for developing blood clots, the use of IXINITY may increase the risk of abnormal blood clots.
  • Call your healthcare provider right away about any side effects that bother you or do not go away, or if your bleeding does not stop after taking IXINITY.
  • The most common side effect that was reported with IXINITY during clinical trials was headache.
  • These are not all the side effects possible with IXINITY. You can ask your healthcare provider for information that is written for healthcare professionals.
For more information about IXINITY, please see full Prescribing Information, including Important Patient Information.
 
You are encouraged to report side effects of prescription drugs to the Food and Drug Administration. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Aptevo BioTherapeutics LLC, Berwyn, PA 19312

IXINITY [coagulation factor IX (recombinant)] and any and all Aptevo BioTherapeutics LLC brand, product, service and feature names, logos, and slogans are trademarks or registered trademarks of Aptevo BioTherapeutics LLC in the United States and/or other countries.

© 2017 Aptevo BioTherapeutics. All rights reserved. CM-FIX-0159

No comments :

 
Bayer